Shares of Novo Nordisk skidded on Tuesday as the Danish drugmaker reduced its expectations on wildly popular drugs Ozempic ...

Novo Nordisk stock (ticker: NVO) fell after the drugmaker unexpectedly cuts its full-year guidance, citing lower sales ...

Danish pharmaceutical giant Novo Nordisk (NYSE:NVO) is watching its stock plummet 20% in morning trading after slashing its ...

While Ozempic is effective at treating type 2 diabetes and supporting weight loss, it can also come with side effects.

Eating disorder centers are facing an influx of people with weight-loss prescriptions. Experts say doctors are ...

Ozempic (semaglutide) and other GLP-1 medications have helped many people lose weight and manage chronic conditions like type ...

The announcement came amid a slump in the company's share price and investor concerns about its experimental drug pipeline ...

Ozempic and Mounjaro are both very popular for weight loss at the minute, but there's one big difference between the two ...

The explosive popularity of GLP-1 weight-loss medications such as Ozempic®, Wegovy®, and Mounjaro® has transformed obesity care and created an unexpected cosmetic challenge. Rapid fat loss can leave ...

The overarching commonality is that there isn't one: "Not all people experiences the same degree of facial and body changes ...

Ozempic and Zepbound are both prescription injections that are part of the GLP-1 drug class. They have different active ...